Poizot-Martin I - Search Results

1

Kaposi's Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition.

Palich R, Makinson A, Veyri M, Guihot A, Valantin MA, Brégigeon-Ronot S, Poizot-Martin I, Solas C, Grabar S, Martin-Blondel G, Spano JP. Palich R, et al. Cancers (Basel). 2021 Nov 15;13(22):5702. doi: 10.3390/cancers13225702. Cancers (Basel). 2021. PMID: 34830857 Free PMC article. Review.

2

Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma.

Rosenthal E, Poizot-Martin I, Saint-Marc T, Spano JP, Cacoub P; DNX Study Group. Rosenthal E, et al. Am J Clin Oncol. 2002 Feb;25(1):57-9. doi: 10.1097/00000421-200202000-00012. Am J Clin Oncol. 2002. PMID: 11823698 Clinical Trial.

3

High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen.

Solas C, Basso S, Poizot-Martin I, Ravaux I, Gallais H, Gastaut JA, Durand A, Lacarelle B. Solas C, et al. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):374-7. doi: 10.1097/00126334-200204010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 11917242

4

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, Allegre T, Mokhtari M, Moreau J, Lepeu G, Petit N, Durand A, Lacarelle B. Solas C, et al. Br J Clin Pharmacol. 2004 Apr;57(4):436-40. doi: 10.1046/j.1365-2125.2003.02020.x. Br J Clin Pharmacol. 2004. PMID: 15025741 Free PMC article.

5

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients.

Allavena C, Ferré V, Brunet-François C, Delfraissy JF, Lafeuillade A, Valantin MA, Bentata M, Michelet C, Poizot-Martin I, Dailly E, Launay O, Raffi F; Bitherapy Kaletra-Sustiva Study Group. Allavena C, et al. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):300-6. doi: 10.1097/01.qai.0000165914.42827.bb. J Acquir Immune Defic Syndr. 2005. PMID: 15980689 Clinical Trial.

6

Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients.

Solas C, Simon N, Drogoul MP, Quaranta S, Frixon-Marin V, Bourgarel-Rey V, Brunet C, Gastaut JA, Durand A, Lacarelle B, Poizot-Martin I. Solas C, et al. Br J Clin Pharmacol. 2007 Sep;64(3):353-62. doi: 10.1111/j.1365-2125.2007.02903.x. Epub 2007 May 22. Br J Clin Pharmacol. 2007. PMID: 17517050 Free PMC article.

7

The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.

Solas C, Colson P, Ravaux I, Poizot-Martin I, Moreau J, Lacarelle B, Tamalet C. Solas C, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):177-80. doi: 10.1097/QAI.0b013e318164226a. J Acquir Immune Defic Syndr. 2008. PMID: 18197119

8

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study.

Lanoy E, Spano JP, Bonnet F, Guiguet M, Boué F, Cadranel J, Carcelain G, Couderc LJ, Frange P, Girard PM, Oksenhendler E, Poizot-Martin I, Semaille C, Agut H, Katlama C, Costagliola D; ONCOVIH study group. Lanoy E, et al. Int J Cancer. 2011 Jul 15;129(2):467-75. doi: 10.1002/ijc.25903. Epub 2011 Apr 27. Int J Cancer. 2011. PMID: 21207370 Free article.

9

Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.

Makinson A, Tenon JC, Eymard-Duvernay S, Pujol JL, Allavena C, Cuzin L, Poizot-Martin I, de la Tribonnière X, Cabié A, Pugliese P, Reynes J, Le Moing V. Makinson A, et al. J Thorac Oncol. 2011 Jun;6(6):1022-9. doi: 10.1097/JTO.0b013e318217b6e0. J Thorac Oncol. 2011. PMID: 21512403 Free article.

10

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.

Allavena C, Flandre P, Pugliese P, Valantin MA, Poizot-Martin I, Cabié A, Melliez H, Cuzin L, Duvivier C, Dellamonica P, Raffi F; Dat'aids Group. Allavena C, et al. Scand J Infect Dis. 2012 Jan;44(1):37-43. doi: 10.3109/00365548.2011.598870. Epub 2011 Aug 19. Scand J Infect Dis. 2012. PMID: 21851330

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page